|
THAP9 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.08489999997674E-06 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
9.237800E-02 |
| Stage1-vs-Stage3 |
2.684300E-02 |
| Stage1-vs-Stage4 |
3.244300E-04 |
| Stage2-vs-Stage3 |
9.697000E-03 |
| Stage2-vs-Stage4 |
4.212700E-04 |
| Stage3-vs-Stage4 |
7.941700E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.38869999943836E-08 |
| Normal-vs-Asian |
<1E-12 |
| Caucasian-vs-AfricanAmerican |
5.207400E-01 |
| Caucasian-vs-Asian |
7.346600E-01 |
| AfricanAmerican-vs-Asian |
6.416400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
9.636600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(81-100Yrs) |
1.70661999999711E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.016800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.705600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.798400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.945000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.956600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.918600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.12960000020479E-07 |
| Classical-VS-Follicular |
1.39040000002311E-06 |
| Classical-VS-Other |
4.787400E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
2.19624318731348E-12 |
| Tall-VS-Other |
3.542400E-02 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
2.875800E-01 |
| Follicular-VS-Normal |
1.21230000005301E-06 |
| Other-VS-Normal |
2.419300E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.11022302462516E-15 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
8.205200E-04 |
|
|
